Fifth Third Bancorp’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$72.3M Buy
1,191,379
+624,735
+110% +$36.4M 0.13% 137
2025
Q4
$30.6M Sell
566,644
-101,510
-15% -$4.88M 0.1% 157
2025
Q3
$30.1M Sell
668,154
-23,334
-3% -$1.09M 0.1% 158
2025
Q2
$32M Sell
691,488
-42,702
-6% -$2.1M 0.11% 151
2025
Q1
$44.8M Sell
734,190
-1,454
-0.2% -$84.8K 0.17% 121
2024
Q4
$41.6M Buy
735,644
+55,803
+8% +$3.12M 0.15% 128
2024
Q3
$35.2M Sell
679,841
-32,613
-5% -$1.53M 0.13% 141
2024
Q2
$29.6M Sell
712,454
-107,758
-13% -$4.82M 0.11% 149
2024
Q1
$44.5M Sell
820,212
-96,201
-10% -$4.9M 0.17% 124
2023
Q4
$47M Sell
916,413
-334,744
-27% -$17.6M 0.2% 118
2023
Q3
$72.6M Sell
1,251,157
-191,467
-13% -$11.7M 0.34% 84
2023
Q2
$92.3M Sell
1,442,624
-88,519
-6% -$5.94M 0.41% 67
2023
Q1
$106M Sell
1,531,143
-17,618
-1% -$1.24M 0.49% 54
2022
Q4
$111M Sell
1,548,761
-25,488
-2% -$1.92M 0.54% 50
2022
Q3
$112M Buy
1,574,249
+79,884
+5% +$5.79M 0.58% 41
2022
Q2
$115M Buy
1,494,365
+87,155
+6% +$6.64M 0.56% 40
2022
Q1
$103M Buy
1,407,210
+98,414
+8% +$6.61M 0.42% 59
2021
Q4
$81.6M Sell
1,308,796
-223,953
-15% -$13.1M 0.32% 77
2021
Q3
$90.7M Sell
1,532,749
-35,454
-2% -$2.33M 0.39% 62
2021
Q2
$105M Sell
1,568,203
-128,121
-8% -$8.35M 0.46% 51
2021
Q1
$107M Sell
1,696,324
-100,538
-6% -$6.26M 0.5% 50
2020
Q4
$111M Sell
1,796,862
-30,851
-2% -$1.9M 0.55% 45
2020
Q3
$110M Buy
1,827,713
+174,048
+11% +$10.5M 0.61% 41
2020
Q2
$97.2M Buy
1,653,665
+4,284
+0.3% +$256K 0.58% 41
2020
Q1
$91.9M Sell
1,649,381
-88,852
-5% -$5.43M 0.66% 36
2019
Q4
$112M Buy
1,738,233
+420,016
+32% +$24.1M 0.62% 39
2019
Q3
$66.8M Sell
1,318,217
-17,988
-1% -$845K 0.4% 67
2019
Q2
$60.6M Sell
1,336,205
-172,666
-11% -$8.04M 0.37% 71
2019
Q1
$72M Buy
1,508,871
+327,714
+28% +$16.3M 0.46% 58
2018
Q4
$61.4M Sell
1,181,157
-65,171
-5% -$3.5M 0.45% 58
2018
Q3
$77.4M Buy
1,246,328
+190,956
+18% +$11.3M 0.49% 53
2018
Q2
$58.4M Buy
1,055,372
+30,869
+3% +$1.67M 0.4% 69
2018
Q1
$64.8M Buy
1,024,503
+29,231
+3% +$1.88M 0.44% 65
2017
Q4
$61M Buy
995,272
+13,097
+1% +$819K 0.41% 72
2017
Q3
$62.6M Sell
982,175
-19,022
-2% -$1.11M 0.45% 65
2017
Q2
$55.8M Sell
1,001,197
-182,476
-15% -$9.93M 0.41% 73
2017
Q1
$64.4M Buy
1,183,673
+115,256
+11% +$6.32M 0.49% 53
2016
Q4
$62.4M Sell
1,068,417
-35,790
-3% -$1.96M 0.5% 54
2016
Q3
$59.5M Sell
1,104,207
-220,547
-17% -$14.2M 0.49% 55
2016
Q2
$97.4M Buy
1,324,754
+140,206
+12% +$9.91M 0.83% 24
2016
Q1
$75.7M Buy
1,184,548
+83,650
+8% +$5.28M 0.65% 35
2015
Q4
$75.7M Buy
1,100,898
+62,299
+6% +$4.12M 0.66% 31
2015
Q3
$61.5M Buy
1,038,599
+11,475
+1% +$728K 0.57% 42
2015
Q2
$68.3M Sell
1,027,124
-38,367
-4% -$2.53M 0.6% 37
2015
Q1
$68.7M Sell
1,065,491
-96,953
-8% -$6.07M 0.59% 40
2014
Q4
$68.6M Sell
1,162,444
-8,269
-0.7% -$466K 0.59% 40
2014
Q3
$59.9M Buy
1,170,713
+62,949
+6% +$3.14M 0.55% 48
2014
Q2
$53.7M Buy
1,107,764
+50,292
+5% +$2.48M 0.49% 51
2014
Q1
$54.9M Sell
1,057,472
-3,996
-0.4% -$213K 0.52% 49
2013
Q4
$56.4M Sell
1,061,468
-14,252
-1% -$726K 0.55% 44
2013
Q3
$49.8M Sell
1,075,720
-12,990
-1% -$570K 0.51% 50
2013
Q2
$48.7M Buy
+1,088,710
New +$47.3M 0.52% 47

Other funds holding BMY

Fifth Third Bancorp's BMY Position: Q1 2026 in Review

Fifth Third Bancorp increased its Bristol-Myers Squibb (BMY) stake by 110% in Q1 2026, buying an estimated $36.4M and bringing the position to 1,191,379 shares worth $72.3M. The position accounts for 0.13% of the portfolio, ranked #137.

Fifth Third Bancorp first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $115M in Q2 2022. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Fifth Third Bancorp held 1,191,379 shares of Bristol-Myers Squibb worth $72.3M as of Q1 2026.
  • Fifth Third Bancorp bought 624,735 Bristol-Myers Squibb shares in Q1 2026, an estimated $36.4M.
  • Bristol-Myers Squibb made up 0.13% of Fifth Third Bancorp's portfolio in Q1 2026, its #137 holding.
  • Fifth Third Bancorp first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Fifth Third Bancorp's Bristol-Myers Squibb position peaked at $115M in Q2 2022.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.